Main description:

How digital therapies can transform your health.

Traditional health care has a new ally. Some patients with sleep disorders, back pain, and diabetes are now being prescribed app-based treatment instead of drugs. Algorithms are helping cancer patients manage their symptoms, and video games are improving the attention span of children diagnosed with ADHD. A new class of medicine called digital therapeutics (DTx) is gaining traction and transforming the way patients engage with the health care system. In Medicine without Meds, Dean Ho, Yoann Sapanel, and Agata Blasiak explore the exciting potential for these digital therapies to transform patient care.

Ho, Sapanel, and Blasiak share their insights on how these therapies can deliver value beyond the technology, address the challenges of implementation in existing health care models, and revolutionize care delivery. These clinicians, researchers, engineers, patients, start-up founders, and corporate executives are at the forefront of designing and building tomorrow's DTx. They explain what DTx represents, how it differs from other digital health solutions, and how these tools can be conceptualized, created, and brought to market. Throughout, case studies from leading DTx organization such as Akili Interactive, MedRhythms, and Welldoc illuminate best practices in product development, issues to consider, and pitfalls to avoid. These essays, along with a foreword by D. A. Wallach and Dr. Eddie Martucci's outlook on the future of DTx, present the exciting potential for DTx to reimagine health care for all.

Contents:

Foreword by D.A. Wallach: It is time for healthcare to embrace patients
Preface
Introduction: The Context
Part I: What Are Digital Therapeutics?
1. Digital Health Solutions Versus Digital Therapeutics
Part II: The Right Tool for The Right Problem
1. Addressing Unmet Stakeholder Needs
2. Addressing Unmet Clinical Needs
3. Ensuring Business Viability Early
4. Test, Learn, and Pivot
Part III: From Pilot to Production
5. Data Sourcing and Management
6. Gathering Evidence: Novel Approaches to Clinical Validation
7. Factors That Influence the Implementation of New Technologies
8. Recommendations for DTx Implementation
9. Supporting Adoption of DTx
Part IV: Paths to Commercialization
10. Channel Partnerships: The Ultimate Commercialization Strategy
11. The Price is Right:: Value in The Eye of The Beholder
Conclusion by Dr Eddie Martucci: The Future of DTx
Appendix
Bibliography
Acknowledgments
Index